Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Schmidt

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecular Cancer Therapeutics|October 15, 2009
A modeling analysis of the effects of molecular size and binding affinity on tumor targetingMichael M Schmidt, K Dane Wittrup
Trends in Pharmacological Sciences|January 9, 2008
Factors determining antibody distribution in tumorsGreg M Thurber, Michael M Schmidt, K Dane Wittrup
Advanced Drug Delivery Reviews|June 11, 2008
Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearanceGreg M Thurber, Michael M Schmidt, K Dane Wittrup
Cancer Immunology, Immunotherapy : CII|April 15, 2008
Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stabilityMichael M Schmidt, Greg M Thurber, K Dane Wittrup
Methods in Enzymology|January 11, 2012
Practical theoretic guidance for the design of tumor-targeting agentsK Dane Wittrup, Greg M Thurber, Michael M Schmidt, et al.
Expert Opinion on Drug Delivery|May 31, 2022
Intratumorally anchored cytokine therapyK Dane Wittrup, Howard L Kaufman, Michael M Schmidt, et al.
JCI Insight|December 8, 2023
Intratumoral aluminum hydroxide-anchored IL-12 drives potent antitumor activity by remodeling the tumor microenvironmentSailaja Battula, Gregory Papastoitsis, Howard L Kaufman, et al.
Deutsche Medizinische Wochenschrift (1946)|April 14, 2021
[Bempedoic Acid]Michael Wagner, Julian Leefmann, Stephan R Künzel, et al.
Molecular Cancer Therapeutics|March 13, 2025
A pharmacokinetic and pharmacodynamic model of an interleukin-12 (IL-12) anchored-drug conjugate for the treatment of solid tumorsHitesh B Mistry, David Hodson, Sailaja Battula, et al.
BMC Developmental Biology|April 12, 2008
Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergenceAngela J Dibenedetto, Jake B Guinto, Timothy D Ebert, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular Cancer Therapeutics|October 15, 2009
A modeling analysis of the effects of molecular size and binding affinity on tumor targetingMichael M Schmidt, K Dane Wittrup
Trends in Pharmacological Sciences|January 9, 2008
Factors determining antibody distribution in tumorsGreg M Thurber, Michael M Schmidt, K Dane Wittrup
Advanced Drug Delivery Reviews|June 11, 2008
Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearanceGreg M Thurber, Michael M Schmidt, K Dane Wittrup
Cancer Immunology, Immunotherapy : CII|April 15, 2008
Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stabilityMichael M Schmidt, Greg M Thurber, K Dane Wittrup
Methods in Enzymology|January 11, 2012
Practical theoretic guidance for the design of tumor-targeting agentsK Dane Wittrup, Greg M Thurber, Michael M Schmidt, et al.
Expert Opinion on Drug Delivery|May 31, 2022
Intratumorally anchored cytokine therapyK Dane Wittrup, Howard L Kaufman, Michael M Schmidt, et al.
JCI Insight|December 8, 2023
Intratumoral aluminum hydroxide-anchored IL-12 drives potent antitumor activity by remodeling the tumor microenvironmentSailaja Battula, Gregory Papastoitsis, Howard L Kaufman, et al.
Deutsche Medizinische Wochenschrift (1946)|April 14, 2021
[Bempedoic Acid]Michael Wagner, Julian Leefmann, Stephan R Künzel, et al.
Molecular Cancer Therapeutics|March 13, 2025
A pharmacokinetic and pharmacodynamic model of an interleukin-12 (IL-12) anchored-drug conjugate for the treatment of solid tumorsHitesh B Mistry, David Hodson, Sailaja Battula, et al.
BMC Developmental Biology|April 12, 2008
Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergenceAngela J Dibenedetto, Jake B Guinto, Timothy D Ebert, et al.
Pageof 2